| Title : Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications - Espay_2018_Mov.Disord_33_1769 |
| Author(s) : Espay AJ , Guskey MT , Norton JC , Coate B , Vizcarra JA , Ballard C , Factor SA , Friedman JH , Lang AE , Larsen NJ , Andersson C , Fredericks D , Weintraub D |
| Ref : Movement Disorder , 33 :1769 , 2018 |
| Abstract : |
| PubMedSearch : Espay_2018_Mov.Disord_33_1769 |
| PubMedID: 30387904 |
| Title : Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications - Espay_2018_Mov.Disord_33_1769 |
| Author(s) : Espay AJ , Guskey MT , Norton JC , Coate B , Vizcarra JA , Ballard C , Factor SA , Friedman JH , Lang AE , Larsen NJ , Andersson C , Fredericks D , Weintraub D |
| Ref : Movement Disorder , 33 :1769 , 2018 |
| Abstract : |
| PubMedSearch : Espay_2018_Mov.Disord_33_1769 |
| PubMedID: 30387904 |
| Title : Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications - Espay_2018_Mov.Disord_33_1769 |
| Author(s) : Espay AJ , Guskey MT , Norton JC , Coate B , Vizcarra JA , Ballard C , Factor SA , Friedman JH , Lang AE , Larsen NJ , Andersson C , Fredericks D , Weintraub D |
| Ref : Movement Disorder , 33 :1769 , 2018 |
| Abstract : |
| PubMedSearch : Espay_2018_Mov.Disord_33_1769 |
| PubMedID: 30387904 |